Podchaser Logo
Home
From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

Released Sunday, 21st May 2023
Good episode? Give it some love!
From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions, Joins BioTalk

Sunday, 21st May 2023
Good episode? Give it some love!
Rate Episode

Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode of BioTalk with Rich Bendis, featuring Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions. In this enlightening discussion, Dr. Grammer unveils the secrets behind Ampel's remarkable success in precision medicine, making this episode a must-listen. Learn about the groundbreaking genomic tests developed by Ampel, providing decision support for autoimmune diseases, and delve into the role of artificial intelligence in predicting potential treatments.

Explore the immense potential for a revolution in healthcare as Dr. Grammer shares insights on understanding the human genome and Ampel's cutting-edge work in harnessing Big Data and Machine Learning for personalized precision medicine. Don't miss this great episode and gain valuable insights into the future of data-driven health.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features